Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. - sprookjes - yvandenbroek - TriplyDB

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q34140986

about

Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study.Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery Metabolic characterization of triple negative breast cancer.Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy A Canadian national expert consensus on neoadjuvant therapy for breast cancer: linking practice to evidence and beyond Metabolic Signatures of Human Breast Cancer.Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI Metabolomic characterisation of the effects of oncogenic PIK3CA transformation in a breast epithelial cell line.Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities.Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer.Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach.Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.MRI and (31)P magnetic resonance spectroscopy hardware for axillary lymph node investigation at 7T.Metabolic Footprints and Molecular Subtypes in Breast Cancer.

P2860

Q33618878-EEC4D618-6FBC-444B-ABA1-83F7AFB80EAC Q33687106-3D03A622-4044-43E6-8DA2-3FF3961745CE Q33844930-21150CF5-4ECF-4AB8-96BB-C65497D320AF Q34339067-A926886E-B6B9-4659-8623-96E59042B489 Q34684585-DE71C18A-025E-4DC9-ADE6-E73CD400EDB7 Q34967995-3B1CC5E3-090D-48F9-9D5A-A09437E6681D Q35075617-76DF9860-2C79-4D5F-90B9-B10D0F943BE6 Q35239617-21401F29-7FFD-49F4-B7C2-FB6367087915 Q35627478-9709FC59-8D9C-40AE-BA59-D437E710FF2C Q36086056-2C681958-CC74-467C-AC9C-4A4F8014B478 Q37743312-0A77E036-7822-4093-BFC6-B05E889C3ADE Q38760909-CAD5392B-72B6-4A8F-8C46-EEBD3F4A18BC Q42039436-EF1E2BD9-3600-470D-B02B-0B280C2817C7 Q42441848-0EC28142-C00D-4878-8C93-515ACE8271C2 Q42637114-C369C91A-F8F7-4D70-8657-0A69EB6B84CD Q47111053-81560F60-1BE7-4E1F-BC47-0E27A433972D Q48338205-455D74B4-346E-4FD7-9BC8-A575BAE72715 Q48733630-F0E398EE-4089-4372-A50D-4858D634B244 Q49871101-2125E964-1879-4ACC-82AF-F97D7DF39587

P2860

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q34140986

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@ast

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@en

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@nl

type

label

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@ast

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@en

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@nl

prefLabel

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@ast

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@en

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@nl

P1433

Q34140986-02668B64-96D3-4A46-B94B-F2B3039CCADC

P1476

Q34140986-942C8BD1-3336-431B-BDCA-1B45DF142CEC

P2093

Q34140986-C6CB27E3-3F59-49B4-B369-2C4FDDBE2AAF

Q34140986-E7E19992-76FB-42A9-854F-3B9D81D543B6

Q34140986-F002832D-E978-4768-9287-78A07F6CB23E

P2860

Q34140986-055DE39F-E1EA-47BE-9C71-5316800E196D

Q34140986-056B9520-7F64-47B9-B592-9EDA2CC67C22

Q34140986-07515F14-6103-432F-86E3-08FBC03A87FF

Q34140986-106EBAC9-6C8C-4081-80FA-4363DABECF57

Q34140986-2DC9ADE9-A8C7-4555-9001-B9068EB96F09

Q34140986-2EF1F813-8510-45A2-B7A3-CD24FB5F32B3

Q34140986-2FECA847-8EC5-4E95-BDA5-1B4BAFA44120

Q34140986-4A4CE607-9A9A-489B-8A72-50DFB107B7F4

Q34140986-4F3899D7-0E5C-48A5-98E2-9BAD07D54A81

Q34140986-4F4E27E5-8BEF-4FEF-9957-3C1C1558BD55

P2888

Q34140986-44A46D5B-0C1A-4965-84B3-DAB34E715292

P304

Q34140986-CFAEFEE0-50CD-4716-9A99-36D287260BCE

P31

Q34140986-1429942D-0F25-4C99-B2C6-89BDDA2EBDCA

P356

Q34140986-AEB62C5A-88B6-4D91-88D7-7C2F33CC734A

P407

Q34140986-D2A8DC1B-8F50-44AA-B214-F967250EAA32

P478

Q34140986-DEDBC8D2-9C4E-4FBE-B7E5-1D9D82C223E9

P50

Q34140986-2439606F-6B47-4875-A353-D930591FB03E

Q34140986-94B35215-35B1-47E8-B4D0-5FC05B53036B

Q34140986-99A769CA-18ED-4694-A067-47DE697B7DB4

Q34140986-C4D1828A-DA6B-4D46-903B-E1EEF112E517

Q34140986-FA479B61-7B73-4023-9FD9-FD0392EE2719

P577

Q34140986-AC4A1F1C-88C6-4309-8252-8065897930C6

P5875

Q34140986-06B5FD8D-A9B8-4222-AC7D-1253A707C3DE

P6179

Q34140986-D8F1B8AD-57D0-48D7-8AA7-F7F70C17A7BE

P698

Q34140986-404130A5-89B5-40E0-80C2-E6E6390E24C1

P921

Q34140986-7633F24D-830C-496E-AF8E-CDD45865370B

P932

Q34140986-1741D11E-13EC-4BA7-91D8-F9432497E0E9

P356

1471-2407-12-39

P1433

P1476

Prognostic value of metabolic ...... ving neoadjuvant chemotherapy.

@en

P2093

Anna Bofin

http://www.w3.org/2001/XMLSchema#string

Guro F Giskeødegård

http://www.w3.org/2001/XMLSchema#string

Maria D Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer.

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression

Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis

Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells

Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

P2888

1471-2407-12-39

P304

39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-12-39

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Per Eystein Lønning

Ingrid Susann Gribbestad

Steinar Lundgren

P577

2012-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221777214

http://www.w3.org/2001/XMLSchema#string

P6179

1011778529

http://www.w3.org/2001/XMLSchema#string

P698

22277092

http://www.w3.org/2001/XMLSchema#string

P921

P932

3307437

http://www.w3.org/2001/XMLSchema#string